Instrument Inactif

Autres langues Tetraphase Pharmaceuticals, Inc.

Actions

US88165N2045

Produits pharmaceutiques

Autres langues

18/12/20	Tetraphase Pharmaceuticals, Inc. Enters into A Termination of Lease and Voluntary Surrender of Premises Agreement
13/10/20	Tetraphase Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2020
31/07/20	La Jolla Pharmaceutical Completes Merger with Tetraphase Pharmaceuticals
29/07/20	Tetraphase Pharmaceuticals, Inc. Announces Executive Changes
29/07/20	Tetraphase Pharmaceuticals, Inc. Announces Resignation of Larry Edwards as CEO
29/07/20	Tetraphase Pharmaceuticals, Inc. Announces Appointment of Michael Hearne as Chief Financial Officer
29/07/20	Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from S&P TMI Index
28/07/20	La Jolla Pharmaceutical Company completed the acquisition of Tetraphase Pharmaceuticals, Inc..
30/06/20	Armistice Capital Enters into Support Agreement with La Jolla Pharmaceutical
26/06/20	Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from Russell Microcap Value Index
26/06/20	Tetraphase Pharmaceuticals, Inc.(NasdaqGS:TTPH) dropped from Russell Microcap Index
25/06/20	La Jolla Pharmaceutical Company : to Acquire Tetraphase Pharmaceuticals, Inc
24/06/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
24/06/20	Tetraphase Pharmaceuticals : La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
24/06/20	Melinta Therapeutics, Inc. cancelled the acquisition of Tetraphase Pharmaceuticals, Inc..
22/06/20	La Jolla Pharmaceutical Sends Letter to Tetraphase Pharmaceuticals
22/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
22/06/20	Tetraphase Pharmaceuticals : Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta
05/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)
05/06/20	United States Food and Drug Administration Approves XERAVA of Tetraphase Pharmaceuticals, Inc
04/06/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
04/06/20	Tetraphase Pharmaceuticals : Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
04/06/20	Tetraphase Pharmaceuticals : AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
04/06/20	AcelRx Pharmaceuticals, Inc. cancelled the acquisition of Tetraphase Pharmaceuticals, Inc..
01/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)